Hassan Rasouli

Dr. Hassan Rasouli

Agricultural Biotechnology, Tarbiat Modares, Tehran, Tehrān, Iran
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2017 in Food & Function
Verified
Journal Article
Closed access
PDF file
Hassan RasouliHassan Rasouli
Hassan Rasouli
SHSeyed Mohammad-Bagher Hosseini-Ghazvini
Seyed Mohammad-Bagher Hosseini-Ghazvini
HAHadi Adibi
Hadi Adibi
Reza KhodarahmiReza Khodarahmi
Reza Khodarahmi
Recently, due to their biological properties, polyphenol-rich functional foods have been proposed to be unique supplementary and nutraceutical treatments for diabetes mellitus. Inhibition of α-amylase and α-glucosidase enzymes using natural products (especially polyphenols) is a novel oral policy to regulate carbohydrate metabolism and hyperglycemia. The present study aims to evaluate the α-amylase and α-glucosidase inhibitory activity of 26 polyphenols using molecular docking and virtual screening studies. The results speculate that among selected compounds caffeic acid, curcumin, cyanidin, daidzein, epicatechin, eridyctiol, ferulic acid, hesperetin, narenginin, pinoresinol, quercetin, resveratrol and syringic acid can significantly inhibit the α-glucosidase enzyme. In addition, catechin, hesperetin, kaempferol, silibinin and pelargonidin are potent α-amylase inhibitors. Therefore the primary structure of polyphenols can change the inhibitory effect versus the α-amylase and α-glucosidase enzymes. Finally, we speculate that consumption of polyphenol-rich functional foods (by considering the best dose of each compound and assessing their possible side effects) in diabetic patients may be useful for regulating carbohydrate metabolism and related disorders. The findings of the current study may also shed light on a way of generating a new class of amylase/glucosidase inhibitors that will discriminately inhibit the on-target enzymes with negligible undesired off-target side effects.

4 August 2017 in International Journal of Food Properties
Verified
Journal Article
Closed access
Hassan RasouliHassan Rasouli
Hassan Rasouli
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
Reza KhodarahmiReza Khodarahmi
Reza Khodarahmi
“Let food be thy medicine and medicine be thy food” was expressed by Hippocrates more than 2000 years ago and the health benefits of natural food products have been considered for different goals since the ancient times. As natural phytochemicals, phenolic compounds (PCs) are a major class of semi-water-soluble compounds (from fruit and vegetable sources) with one or more benzene rings that are generally found in nature as glycosides. According to a review of the literature, food scientists have studied the many health benefits of these compounds against pernicious human diseases (HDs). Today, choosing a healthy diet has become an essential part of healthy living and fitness. Many studies have shown that people who follow a specific diet (especially polyphenol-rich diets) are at a low risk for a range of chronic diseases, such as obesity, diabetes, cancer, heart disease, etc. The present research is a comprehensive review of studies on PCs with a focus on HDs that seeks to find out why some PCs have received such considerable attention all over the world. Data were collected from the Scopus database and a hierarchical cluster analysis was used with Ward’s method to analyze the data. The results showed that three countries most involved in research on PCs are USA, China, and India, and also found that quercetin, catechin, and kaempferol are the three most studied PCs. Cardiovascular diseases, cancer, obesity, diabetes, and infectious diseases are the major treatment targets for PCs. The review of the literature showed that these compounds share a common molecular mode of action against HDs. The Journal of Agriculture and Food Chemistry, Food Chemistry, PLOS ONE, and Planta Medica are also the most popular journals for covering original research on PCs. However, this study seeks to facilitate future studies on PCs through its findings. Abbreviations: ROS: Reactive oxygen species; DPPH: 2,2-diphenyl-1-picrylhydrazyl; ABTS: 2,2′-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid); DMPD: Dimethyl-4-phenylenediamine; COX: Cyclooxygenase; PI3K: phosphoinositide 3-kinase; ERK: extracellular signal-regulated kinase; GalR: galanin receptor; PKC : protein kinase C delta type; Bcl-2: B-cell lymphoma 2; PPARγ: peroxisome proliferator-activated receptor gamma; LDL: Low-density lipoprotein; HIV: human Immunodeficiency Virus; HDACs; histone deacetylases; SREBP-1c; sterol regulatory element-binding proteins; GLUT: glucose transferase; RAGE: receptor for advanced glycation end products; TRAIL: tumor necrosis factor-related apoptosis-inducing ligand; TNF-α: tumor necrosis factor α; PKC: protein kinase C; IRS: insulin receptor substrate; NFκB: nuclear factor-κB; JNK: c-jun amino terminal kinase; MAPK: mitogen activated protein kinase; PEPCK: phosphoenolpyruvatecarboxykinase; G6Pase: glucose-6-phosphatase; RNS: reactive nitrogen species; VLDL: very low-density lipoprotein; HDL: high-density lipoprotein; CaMK II: calmodulin kinase II; MCP: Monocyte Chemoattractant Protein; JAK: Janus kinase; STAT: signal transducers and activators of transcription; EGFR: epidermal growth factor receptor; VEGF: vascular endothelial growth factor; VEGFR: vascular endothelial growth factor receptor; PKA: protein kinase A; PTK: protein-tyrosine kinase;AP-1: activator protein 1; Her2/neu: human epidermal growth factor receptor 2;mTOR: the mechanistic target of rapamycin; IL: interleukin; COMT: cathecol-o-methyl transferase; UGT: uridine-5ʹ-diphosphate glucuronosyltransferase; MMP-2: matrix metalloproteinase-2; AhR: the aryl hydrocarbon receptor; CYP: cytochrome P450; DR: death receptor; TGL: triglycerides; TC: total cholesterol; EGCG: (-)-epigallocatechingallate; EGC: (-)-epigallocatechin; ECG: (-)-epicatechingallate; EC: (-)-epicatechin; ELK1: ETS domain-containing protein Elk-1; MAPK: Mitogen-activated protein kinase kinase; HGFR: hepatocyte growth factor receptor; HDAC: histone deacetylase; DNMT: DNA methyl transferase; HAT; histone acetyltransferase; C/EBP-α: CCAAT-enhancer-binding proteins; LPL: Lipoprotein lipase; iNOS: inducible nitric oxide synthase.

1 May 2020 in Pharmacological Research
Verified
Journal Article
Closed access
Hassan RasouliHassan Rasouli
Hassan Rasouli
RYReza Yarani
Reza Yarani
FPFlemming Pociot
Flemming Pociot
Jelena Popović-DjordjevićJelena Popović-Djordjević
Jelena Popović-Djordjević

23 August 2016 in Molecules
Verified
Journal Article
Open access
PDF file
Hassan RasouliHassan Rasouli
Hassan Rasouli
MFMohammad Hosein Farzaei
Mohammad Hosein Farzaei
KMKamran Mansouri
Kamran Mansouri
SMSara Mohammadzadeh
Sara Mohammadzadeh
Reza KhodarahmiReza Khodarahmi
Reza Khodarahmi
Phenolic compounds (PCs) are known as a chemically diverse category of secondary and reactive metabolites which are produced in plants via the shikimate-phenylpropanoid pathways. These compounds—ubiquitous in plants—are an essential part of the human diet, and are of considerable interest due to their antioxidant properties. Phenolic compounds are essential for plant functions, because they are involved in oxidative stress reactions, defensive systems, growth, and development. A large body of cellular and animal evidence carried out in recent decades has confirmed the anticancer role of PCs. Phytohormones—especially auxins and cytokinins—are key contributors to uncontrolled growth and tumor formation. Phenolic compounds can prevent plant growth by the endogenous regulation of auxin transport and enzymatic performance, resulting in the prevention of tumorigenesis. To conclude, polyphenols can reduce plant over-growth rate and the development of tumors in plant cells by regulating phytohormones. Future mechanistic studies are necessary to reveal intracellular transcription and transduction agents associated with the preventive role of phenolics versus plant pathological malignancy cascades.

1 October 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SZSimin Zarayneh
Simin Zarayneh
ASAbbas Akhavan Sepahi
Abbas Akhavan Sepahi
Mehdi JonoobiMehdi Jonoobi
Mehdi Jonoobi
Hassan RasouliHassan Rasouli
Hassan Rasouli

1 March 2017 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Hassan RasouliHassan Rasouli
Hassan Rasouli
SPSharham Parvaneh
Sharham Parvaneh
AMAzadeh Mahnam
Azadeh Mahnam
MRMohsen Rastegari-Pouyani
Mohsen Rastegari-Pouyani
ZHZohreh Hoseinkhani
Zohreh Hoseinkhani
KMKamran Mansouri
Kamran Mansouri